Comprehensive Pharmacogenomics (PGx) Panel

This test evaluates a patient’s metabolizer status for 27 genes, which can aid in appropriate medication selection and dosing to reduce risk of side effects and treatment failure for cancer, cardiovascular disease, pain, mental health and other conditions. Any information provided for drugs listed under "Limited Evidence Drug-Gene Associations" is provided for informational use only. For sections titled “Limited Evidence Drug-Gene Associations,” no interpretation of expected drug response is provided due to a lack of sufficient evidence and/or available guidelines.